Event: ESMO 2018

0:06:35

Raffaele Califano, ESMO 2018 – Mechanisms of resistance in non-small cell lung cancer

0:02:06

Women for Oncology: initiatives at ESMO 2018

0:17:49

ESMO 2018 highlights

0:01:49

HCC clinical trial data from ESMO 2018

0:01:45

Melanoma highlights from ESMO 2018

0:01:22

Uro-Onc data at ESMO 2018: what to look out for

0:02:36

Daniel Kelly, ESMO 2018 – The European Oncology Nurses Society’s RECaN Project

0:01:08

ESMO 2018 - Congress Highlights

0:00:47

EONS and ESMO 2018: nurses and physicians unite

0:02:52

Lena Sharp, ESMO 2018 – The European Oncology Nursing Society

0:07:39

Ovarian news from ESMO 2018: SOLO-1 results for olaparib

0:06:51

Matti Aapro, ESMO 2018 – Immunotherapy in elderly patients

0:05:13

Bernardo Rapoport, ESMO 2018 – Prognostic factors of complete pathological response

0:04:26

Tessa Steenbruggen, ESMO 2018 – High-dose chemotherapy and haematopoietic stem cell transplantation

0:02:15

ESMO 2018 Congress Highlights in advanced renal cell carcinoma

0:05:54

ESMO 2018: Immunotherapy in the Neoadjuvant Setting for Bladder Cancer

0:02:36

Daniel Kelly, ESMO 2018 – The European Oncology Nurses Society’s RECaN Project

0:01:12

Molecular Health at ESMO 2018

0:02:52

Women for Oncology (W4O) at ESMO

0:10:15

Ian Chau, ESMO 2018 – Insight into the RAINFALL trial in ramucirumab plus chemotherapy

0:02:33

ESMO 2018 Congress Highlights in metastatic triple negative breast cancer LBA1 PR

0:07:53

Ooffle - Events - ESMO Asia 2018 Congress Conference @ Suntec Convention

0:01:16

ESMO Asia 2023: Sanjay Popat on the programme of this influential Asia-Pacific oncology event

0:19:52

Controversy Debate 4: Treatment algorithms in metastatic CRC - ESMO guidelines